Virtus LifeSci Biotech Pr... (BBP)
NYSEArca: BBP
· Prix en temps réel · USD
103.48
+0.75 (0.73%)
À la clôture : Aug 18, 2026, 3:50 PM
Virtus LifeSci Biotech Products ETF (BBP) ETF Price, Holdings & Analysis
0.73% (1D)
| Bid | 0 |
| Capitalisation boursière | n/a |
| AUM | 98.54M |
| NAV | 101.28 |
| Bêta | 0.76 |
| EPS (ttm) | n / A |
| Rapport PE (ttm) | n / A |
| Parts en circulation | n / A |
| Date de création | Dec 16, 2014 |
| Ask | 0 |
| Volume | 6,295 |
| Moy. Volume (20D) | 8,692 |
| Ouverture | 101.99 |
| Clôture précédente | 102.73 |
| Fourchette du jour | 102.92 - 103.48 |
| Intervalle de 52 semaines | 66.55 - 105.21 |
| Positions | n / A |
| Ratio de frais | 0.34% |
À propos de BBP
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
Classe d’actifs Equity
Symbole boursier BBP
Date de création Dec 16, 2014
Fournisseur Virtus
Site web Page d’accueil du fonds
Échange NYSEArca
10 principaux titres 19.61% des actifs
| Nom | Symbole | Poids |
|---|---|---|
| Crinetics Pharmaceut... | CRNX | 3.34% |
| Kiniksa Pharmaceutic... | KNSA | 1.97% |
| Verastem Inc | VSTM | 1.95% |
| Precigen Inc | PGEN | 1.94% |
| Omeros Corp | OMER | 1.87% |
| Nuvation Bio Inc Ord... | NUVB | 1.77% |
| Regeneron Pharmaceut... | REGN | 1.72% |
| Protagonist Therapeu... | PTGX | 1.71% |
| Acadia Pharmaceutica... | ACAD | 1.69% |
| Bridgebio Pharma Inc | BBIO | 1.65% |
Dividendes Rendement du dividende 0.07%
| Ex-dividende | Montant | Date de paiement |
|---|---|---|
| Dec 20, 2017 | $0.0720 | n / A |
| Dec 21, 2015 | $0.3970 | n / A |
